Trials / Sponsors / SignPath Pharma, Inc.
SignPath Pharma, Inc.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas Glioblastoma | Phase 1 / Phase 2 | 2023-03-03 |
| Completed | A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer Patients w/Advanced Cancer That Failed Std of Care Therapy | Phase 1 / Phase 2 | 2014-03-01 |
| Completed | Evaluation of Liposomal Curcumin in Healthy Volunteers Drug Safety | Phase 1 | 2011-08-01 |